OncoTherapy Science, Inc.

TSE:4564.T

32 (JPY) • At close November 5, 2024
Bedrijfsnaam OncoTherapy Science, Inc.
Symbool 4564.T
Munteenheid JPY
Prijs 32
Beurswaarde 8,692,606,368
Dividendpercentage 0%
52-weken bereik 15 - 64
Industrie Biotechnology
Sector Healthcare
CEO Junichi Shimada
Website https://www.oncotherapy.co.jp

An error occurred while fetching data.

Over OncoTherapy Science, Inc.

OncoTherapy Science, Inc. researches and develops anti-cancer medicines and therapies in Japan. Its clinical development product pipeline includes small-molecule drugs, such as OTS167, a maternal embryonic leucine zipper kinase inhibitor that is in Phase I/II clinical trials for the treatment of acute myeloid leukemia, as well as in Phase I

Vergelijkbare Aandelen

Techno Medica Co., Ltd. logo

Techno Medica Co., Ltd.

6678.T

1,777 JPY

MEDINET Co., Ltd. logo

MEDINET Co., Ltd.

2370.T

42 JPY

SEED Co.,Ltd. logo

SEED Co.,Ltd.

7743.T

493 JPY

Medical System Network Co., Ltd. logo

Medical System Network Co., Ltd.

4350.T

412 JPY

Solasia Pharma K.K. logo

Solasia Pharma K.K.

4597.T

47 JPY

JTEC Corporation logo

JTEC Corporation

3446.T

1,660 JPY

Japan Hospice Holdings Inc. logo

Japan Hospice Holdings Inc.

7061.T

1,379 JPY

JMS Co.,Ltd. logo

JMS Co.,Ltd.

7702.T

468 JPY

Carna Biosciences, Inc. logo

Carna Biosciences, Inc.

4572.T

304 JPY

Daiken Medical Co., Ltd. logo

Daiken Medical Co., Ltd.

7775.T

501 JPY

Financiële Gegevens

Cijfers zijn in miljoenen (JPY)

Cijfers zijn in miljoenen (JPY)